Ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-enecarboxylate, 95.0%, 10g

Methyl 2-bromo-4-chlorobenzoate, 95.0%, 5g

(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, 95%, 100mg

Methyl 5-formyl-1-methyl-1H-pyrrole-3-carboxylate, 500mg

(1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl-6-((triethylsilyl)oxy)hept-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-one, 98%, 50mg

H-Lys(Z)-OH, 98%, 100g

Potassium 5-methyl-1,2,4-oxadiazole-3-carboxylate, 95.0%, 5g

2-Fluoroaniline>99.0%(GC)500g

BENZYL 4-OXOSPIRO[CHROMAN-2,4'-PIPERIDINE]-1'-CARBOXYLATE, 95.0%, 1g

Humic acid sodium salt, approx. 45-70%, 25 kg, plastic packaging.

1-Bromo-2-ethylhexane>97.0%(GC)500mL

N-(4,6-dichloro-1,3-benzothiazol-2-yl)-N-methylglycine, 95.0%, 500mg

Methyl 4-bromotetrahydro-2H-pyran-4-carboxylate, 97%, 100mg